Caspase-independent type III PCD: a new means to modulate cell death in chronic lymphocytic leukemia.
about
CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humansNovel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies.Caspase-independent type III programmed cell death in chronic lymphocytic leukemia: the key role of the F-actin cytoskeleton.CD47
P2860
Caspase-independent type III PCD: a new means to modulate cell death in chronic lymphocytic leukemia.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Caspase-independent type III P ...... chronic lymphocytic leukemia.
@en
Caspase-independent type III P ...... chronic lymphocytic leukemia.
@nl
type
label
Caspase-independent type III P ...... chronic lymphocytic leukemia.
@en
Caspase-independent type III P ...... chronic lymphocytic leukemia.
@nl
prefLabel
Caspase-independent type III P ...... chronic lymphocytic leukemia.
@en
Caspase-independent type III P ...... chronic lymphocytic leukemia.
@nl
P2093
P50
P356
P1433
P1476
Caspase-independent type III P ...... chronic lymphocytic leukemia.
@en
P2093
P2888
P304
P356
10.1038/LEU.2008.321
P577
2008-11-13T00:00:00Z
P5875
P6179
1002548487